Long COVID: Symptoms & Latest Research
- As the COVID-19 pandemic continues, attention is turning to the long-term effects experienced by many.
- The global impact of COVID-19 is staggering, with millions of cases and deaths reported.
- PASC is characterized by a range of symptoms that can affect various body systems.Researchers are working to define the condition and understand its prevalence.
Discover the lasting impact of Long COVID: this article dives deep into the persistent and new health problems following a COVID-19 infection, also known as Post-Acute Sequelae of COVID-19 (PASC). uncover the range of symptoms affecting different body systems, including fatigue, cognitive issues, and more, that can linger for weeks or months after the initial illness. We examine the scale of Long COVID, providing insights into its prevalence, backed by studies from the UK and China, and research involving ”long haulers” across 56 countries. Learn about common long-term symptoms, understand how severity of the initial infection doesn’t always predict the long-term impact, and explore ongoing research into this emerging health crisis. News Directory 3 is on hand to help you stay informed. As the understanding of PASC matures, what are the next steps in supporting patients and healthcare systems? Discover what’s next in Long COVID research.
Understanding Long COVID: Symptoms, Prevalence, and PASC Research
Updated June 03, 2025
As the COVID-19 pandemic continues, attention is turning to the long-term effects experienced by many. This condition, known as Long COVID or Post-Acute Sequelae of COVID-19 (PASC), involves persistent or new symptoms that linger for weeks or months after the initial infection.
The global impact of COVID-19 is staggering, with millions of cases and deaths reported. However, these figures may underestimate the true extent due to testing limitations and asymptomatic cases. even as vaccination efforts ramp up, the challenge of managing Long COVID remains notable.
PASC is characterized by a range of symptoms that can affect various body systems.Researchers are working to define the condition and understand its prevalence.
The prevalence of PASC is still being determined, but studies offer insights. Data from the United Kingdom indicated that 1 in 10 people who tested positive for COVID-19 experienced symptoms for 12 weeks or longer. A study in Wuhan, China, found that 76% of discharged patients reported at least one symptom six months after symptom onset.
Another study surveyed over 3,700 “long haulers” from 56 countries, revealing prolonged multisystem involvement and significant disability. Many participants had not returned to their previous work levels six months after symptom onset.
Common symptoms reported for six months or longer include fatigue, post-exertional malaise, cognitive dysfunction, palpitations, and skin rashes. Other symptoms include gastrointestinal issues, tinnitus, blurred vision, joint pain, muscle spasms, brain fog, and memory loss.
Additional symptoms observed in long haulers with symptom duration under six months include chest pain, tachycardia, depression, chest tightness, dizziness, headache, changes in taste and smell, shortness of breath, and insomnia.
Interestingly, over half of the respondents in one study had not been hospitalized during their initial COVID-19 infection, highlighting that PASC can affect individuals with varying degrees of illness severity.
What’s next
As understanding of PASC evolves, it is crucial to prepare for the ongoing burden on patients and healthcare systems. Community rehabilitation services and timely data are essential for supporting patients and managing their condition. Further research is needed to fully understand the long-term economic and health impacts of Long COVID on society.